Jacob Smith

Senior Director, Process Development at Asklepios BioPharmaceuticals Inc - Durham, NC, US

Jacob Smith's Colleagues at Asklepios BioPharmaceuticals Inc
Shari Gordon

Senior Director of Immunology

Contact Shari Gordon

Katie Morris

Purchasing Specialist & Lab Manager

Contact Katie Morris

Paul Greback-Clarke

AAV Process Development Scientist

Contact Paul Greback-Clarke

Leigh Ervin

Director, Clinical Operaions

Contact Leigh Ervin

Lorne Celentano

Research Associate II Animal Technician

Contact Lorne Celentano

Deanna Sedlak

Senior Research Technician

Contact Deanna Sedlak

View All Jacob Smith's Colleagues
Jacob Smith's Contact Details
HQ
919-561-6210
Location
Chapel Hill, North Carolina, United States
Company
Asklepios BioPharmaceuticals Inc
Jacob Smith's Company Details
Asklepios BioPharmaceuticals Inc logo, Asklepios BioPharmaceuticals Inc contact details

Asklepios BioPharmaceuticals Inc

Durham, NC, US • 250 - 499 Employees
BioTech/Drugs

Asklepios BioPharmaceutical, Inc. (AskBio) is a leading clinical-stage adeno-associated virus (AAV) gene therapy company dedicated to improving the lives of patients with rare disorders and other diseases.We've built a foundation of therapeutic programs, AAV manufacturing and a rich portfolio of patented technology. Our therapeutic focus includes neuromuscular, central nervous system, cardiovascular and metabolic diseases with clinical trials underway for Pompe disease, Parkinson's disease, and congestive heart failure. Our gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid and promoter library.We became a wholly-owned, independently operated, subsidiary of Bayer AG in late 2020 as a cornerstone of its newly formed Cell & Gene Therapy (CGT) platform. Our global headquarters is in Research Triangle Park, NC. Additionally, we have significant operations in Philadelphia, PA, Columbus, OH, Scotland, France, and Spain.Vision - Pioneering science to create transformative molecular medicines.Mission - Lead innovative science and drive clinical outcomes to transform people's lives.Values:• Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need.• Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view.• Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers.• Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action.• Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what's right in every situation. Make clear commitments and follow through.

AAV Adeno-Associated Virus Gene Therapy Rare Disease Pro10 AAV Manufacturing BioTech/Drugs Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about Asklepios BioPharmaceuticals Inc
Frequently Asked Questions about Jacob Smith
Jacob Smith currently works for Asklepios BioPharmaceuticals Inc.
Jacob Smith's role at Asklepios BioPharmaceuticals Inc is Senior Director, Process Development.
Jacob Smith's email address is ***@askbio.com. To view Jacob Smith's full email address, please signup to ConnectPlex.
Jacob Smith works in the BioTech/Drugs industry.
Jacob Smith's colleagues at Asklepios BioPharmaceuticals Inc are Shari Gordon, Luis Lazaro, Katie Morris, Paul Greback-Clarke, Leigh Ervin, Lorne Celentano, Deanna Sedlak and others.
Jacob Smith's phone number is 919-561-6210
See more information about Jacob Smith